Thursday, 09 September 2021 / Published in Medical Device, News, NMPA Registration in China

Cisema experts cited in drug-device combination news

Cisema’s regulatory affairs consultant Anna King was recently cited by Bioworld in their article titled
Monday, 23 August 2021 / Published in Medical Device, News, NMPA Registration in China

CMDE Compares EU and China Risk Management

On August 6, 2021, the CMDE (Center for Medical Device Evaluation) of the NMPA (National
Monday, 23 August 2021 / Published in Medical Device, News, NMPA Registration in China

New Preconditions for Marketing Approvals of Combination Products in China

On July 27, 2021, the NMPA (National Medical Products Administration) released the finalized version (No.52-2021)
Monday, 23 August 2021 / Published in Medical Device, News, NMPA Registration in China

China Still Finalizing the Details for Self-Testing on Medical Devices

On July 23, 2021, the NMPA (National Medical Products Administration) published the revised draft of